Sub-Total: $0.00 CAD
Retatrutide 10mg
$90.00 CAD
Retatrutide is a peptide that supports advanced metabolic research by simultaneously targeting three hormone pathways, letting investigators explore deep weight-loss trajectories, glycemic control, and liver-fat changes beyond single- or dual-agonist incretin approaches.
Description
Retatrutide is an investigational, long-acting peptide that activates GLP-1, GIP, and glucagon receptors, studied for its effects on appetite regulation, glucose homeostasis, energy expenditure, and multi-system metabolic pathways in obesity, diabetes, and liver-fat research models.
*Sentient Biogenix products are intended solely for non‑clinical laboratory research. It is not approved by Health Canada, the FDA, or any other regulatory authority, and is not for human or animal consumption, nor for diagnostic, therapeutic, or clinical use.
What others are saying
There are no contributions yet.